DSM-Firmenich AG

BMV:DSM N 주식 보고서

시가총액: Mex$14.4b

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

DSM-Firmenich 과거 수익 실적

과거 기준 확인 1/6

DSM-Firmenich's earnings have been declining at an average annual rate of -20.7%, while the Chemicals industry saw earnings growing at 20.5% annually. Revenues have been declining at an average rate of 0.8% per year. DSM-Firmenich's return on equity is 4.4%, and it has net margins of 5.4%.

주요 정보

-20.7%

수익 성장률

-20.2%

EPS 성장률

Chemicals 산업 성장13.1%
매출 성장률-0.8%
자기자본 수익률4.4%
순이익5.4%
다음 실적 업데이트02 Aug 2023

최근 과거 실적 업데이트

Recent updates

수익 및 비용 분석

DSM-Firmenich 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.

수익 및 매출 내역

BMV:DSM N 수익, 비용 및 수입 (EUR Millions )
날짜수익수익G+A 비용R&D 비용
31 Dec 228,3904541,772295
30 Sep 229,582837895162
30 Jun 229,8021,0821,789323
31 Mar 229,5031,0811,789323
31 Dec 217,2698201,649274
30 Sep 217,9556602,517560
30 Jun 217,5584931,622398
31 Mar 217,5724231,622398
31 Dec 208,1064481,622398
30 Sep 207,9605101,639295
30 Jun 208,0345571,639295
31 Mar 209,0117221,795349
31 Dec 197,9986751,639295
30 Sep 198,2728201,839348
30 Jun 198,5027941,839348
31 Mar 199,1249341,839348
31 Dec 189,2671,0691,839348
30 Sep 189,2359841,753334
30 Jun 189,1062,0821,753334
31 Mar 188,9081,9421,753334
31 Dec 178,6321,7611,753334
30 Sep 178,4711,6761,694309
30 Jun 178,3337381,694309
31 Mar 178,1667111,694309
31 Dec 167,9206451,694309
30 Sep 167,8315881,605332
30 Jun 167,7782741,605332
31 Mar 167,7492141,605332
31 Dec 157,7221741,605332
30 Sep 157,607661,382304
30 Jun 157,4561141,382304
31 Mar 157,2451151,382304
31 Dec 147,0511231,382304
30 Sep 147,4151121,430340
30 Jun 147,8341381,430340
31 Mar 148,3621821,430340
31 Dec 138,8582521,430340
30 Sep 138,4093631,396372
30 Jun 138,5003351,396372
31 Mar 138,4862571,396372
31 Dec 128,5882801,396372
30 Sep 129,0894531,356378
30 Jun 129,1075431,356378

양질의 수익: DSM N has high quality earnings.

이익 마진 증가: DSM N's current net profit margins (5.4%) are lower than last year (11.3%).

잉여현금흐름 대 수익 분석

과거 수익 성장 분석

수익추이: DSM N's earnings have declined by 20.7% per year over the past 5 years.

성장 가속화: DSM N's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

수익 대 산업: DSM N had negative earnings growth (-44.6%) over the past year, making it difficult to compare to the Chemicals industry average (-12.7%).

자기자본 수익률

높은 ROE: DSM N's Return on Equity (4.4%) is considered low.

자산 수익률

고용 자본 수익률

과거 성과가 우수한 기업 찾기

7D

1Y

7D

1Y

7D

1Y